Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06966375 · ClinicalTrials.gov registry record · NA
Worldwide Yearly Screening for Hypospadias
A NA study of Hypospadias, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06966375: Recruiting NA study of Hypospadias, sponsored by University of Wisconsin, Madison.
NCT06966375 is a NA study of Hypospadias that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 20 participants, below the 146-participant average among 3 other Hypospadias trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06966375, a NA study of Hypospadias, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to recruit approximately 20 male participants who have a history of repaired hypospadias to test the feasibility and acceptability of the Care Planning Tool within the Worldwide Yearly Screening for Hypospadias (WYSH) Web Application.
Primary Outcome
The Care Planning Tool within the Worldwide Yearly Screening for Hypospadias (WYSH) Application is a survey containing forty-eight questions regarding possible complications for participating patients (Subsections of penile function, voiding, sexual health, social functioning, psychological health, and doctor-patient communication). These questions will be completed by patients using a five point scale - "Never," "Rarely," "Sometimes," "Often," and "Always" - to populate a Care Plan highlighting
Conditions Studied
Interventions
- OTHER WYSH Web Application
Study Locations (1)
Wisconsin
- UW School of Medicine and Public Health - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-07-23 |
| Est. Completion | 2026-11 |
| Phase | NA |
What NCT06966375 shows while recruiting
NCT06966375 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 146-participant average among 3 other Hypospadias trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Hypospadias appearing as the primary indexed condition, and to 1 intervention - of which WYSH Web Application is the first listed.
NCT06966375 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06966375 about?
NCT06966375 is a clinical study titled "Worldwide Yearly Screening for Hypospadias". The purpose of this study is to recruit approximately 20 male participants who have a history of repaired hypospadias to test the feasibility and acceptability of the Care Planning Tool within the Worldwide Yearly Screening for Hypospadias (WYSH) Web Application.
What is the current status of trial NCT06966375?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-07-23. Estimated completion is 2026-11.
What conditions does trial NCT06966375 study?
This clinical trial studies the following conditions: Hypospadias.
What interventions are being tested in trial NCT06966375?
The interventions under investigation include: WYSH Web Application (OTHER).
Who is sponsoring clinical trial NCT06966375?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06966375 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypospadias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI